Huber 360 Sensorimotor Training: Participants will receive sensorimotor training using the Huber 360 balance system. The protocol will include progressive rotational and oscillatory exercises designed to improve proprioception, balance, neuromuscular control, and movement control in patients with chronic low back pain. Sessions will be performed for 30 minutes, twice weekly for 5 weeks.
Home Exercise Program: Participants will perform a home exercise program including warm-up and stretching exercises, spinal mobility exercises, lumbopelvic control exercises, and balance exercises. The program will be performed for 30 minutes per session, twice weekly for 5 weeks.
This randomized controlled study aims to investigate the effects of a sensorimotor training protocol using a mobilized balance platform device on proprioceptive system function, movement control, balance, physical performance, pain severity, and quality of life in patients with chronic low back pain. A total of 44 patients with chronic low back pain will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.
Participants will be randomly assigned to either a sensorimotor training group or a control group. The intervention group will receive sensorimotor training using the Huber 360 balance system, while the control group will perform a home exercise program including stretching, spinal mobility, lumbopelvic control, and balance exercises.
Pain severity, proprioception, functional status, balance, physical performance, and quality of life will be assessed before and after treatment by an assessor blinded to group allocation.
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Gaziler physical therapy and rehabilitation hospital | Ankara | Turkey (Türkiye) | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07603609 on ClinicalTrials.gov ↗ ← All trials in Turkey